Clinical Trials Browser

Withdrawn × Inotuzumab Ozogamicin × Lymphoid × Clear all

NCT03851081 2022-01-28

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Phase 1/2 Withdrawn

Burkitt Lymphoma

NCT03628053 2020-07-09

OBERON

Phase 3 Withdrawn

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma